The present invention provides binding molecules that specifically bind to SARS-CoV, nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules are capable of specifically binding to SARS-CoV and can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from SAR

 
Web www.patentalert.com

< High throughput prion assays

< Maltose-1-phosphate-producing enzyme

> Method of producing nitride-based compound semiconductor light-emitting device

> Remover composition

~ 00265